Resistant and refractory arterial hypertension: similarities and differences, new approaches to diagnosis and treatment
https://doi.org/10.26442/2075-082X_2018.3.11-13
Abstract
About the Authors
A. V. AksenovaRussian Federation
T. E. Esaulova
Russian Federation
O. A. Sivakova
Russian Federation
I. E. Chazova
Russian Federation
References
1. Calhoun D.A, Jones D, Textor S et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51 (6): 1403-19.
2. Aelajado M.C, Pisoni R, Dudenbostel T et al. Refractory hypertension: definition, prevalence, and patient characteristics. J Clin Hypertens (Greenwich) 2012; 14: 7-12. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults.
3. Dudenbostel T, Calhoun D. Refractory Hypertension a novel phenotype of antihypertensive treatment failure. Hypertension 2016; 67: 1085-92.
4. Диагностика и лечение артериальной гипертонии (клинические рекомендации). Кардиологический вестник. 2015; Х (1).
5. Dudenbostel T, Acelajado M.C, Pisoni R et al. Refractory hypertension: evidence of heightened sympathetic activity as a cause of antihypertensive treatment failure. Hypertension 2015; 66: 126-33.
6. De la Sierra A et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011; 57 (5): 898-902.
7. Muntner P et al. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension 2014; 64 (5): 1012-21.
8. Calhoun D.A, Booth J.N, Oparil S et al. Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Hypertension 2014; 63: 451-8.
9. Чазова И.Е., Данилов Н.М., Литвин А.Ю. Рефрактераня артериальная гипертония. Монография. М.: Атмосфера, 2014.
10. Velasco A, Siddiqui M, Kreps E et al. Refractory hypertension is not attributable to intravascular fluid retention as determined by intracardiac volumes. Hypertension 2018.
11. Irvin M.R, Booth J.N, Shimbo D et al. Calhoun/Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality. J Am Soc Hypertens 2014; 8: 405-13.
12. Armario P, Oliveras A, Blanch P et al. Refractory hypertension: prevalence, associated factors and differences with resistant hypertension. J Hypertension 2017. DOI: 10.1097/01.hjh.0000523892.30290.dd
13. Modolo R, de Faria A.P, Sabbatini A.R et al. Refractory and resistant hypertension: characteristics and differences observed in a specialized clinic. J Am Soc Hypertens 2015; 9: 397-402.
14. Gaddam K.K et al. Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion. Arch Intern Med 2008; 168 (11): 1159-64.
15. Dudenbostel T, Siddiqui M, Gharpure N, Calhoun D. Refractory versus resistant hypertension: Novel distinctive phenotypes. J Nat Sci 2017; 3 (9): e430.
Review
For citations:
Aksenova A.V., Esaulova T.E., Sivakova O.A., Chazova I.E. Resistant and refractory arterial hypertension: similarities and differences, new approaches to diagnosis and treatment. Systemic Hypertension. 2018;15(3):11-13. https://doi.org/10.26442/2075-082X_2018.3.11-13
Email this article 